Evaluation of EVI1 and EVI1s (Δ324) as potential therapeutic targets in ovarian cancer

Gynecologic Oncology

Volumn 118, Issue 2, 2010, Pages 189-195

  Jazaeri, Amir A ^a   Ferriss, J Stuart ^a   Bryant, Jennifer L ^a   Dalton, M Susan ^a   Dutta, Anindya ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

324; EVI1; MDS1 EVI1; MECOM; Ovarian Cancer

Indexed keywords

CISPLATIN; ECOTROPIC VIRAL INTEGRATION SITE 1; ISOPROTEIN; MESSENGER RNA; ONCOPROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; FIMBRIA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; UBIQUITINATION; UTERINE TUBE;

APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CISPLATIN; DNA DAMAGE; DNA-BINDING PROTEINS; DRUG DELIVERY SYSTEMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 77954243289     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.04.007     Document Type: Article

References (19)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 Jul-Aug 2009 225 249
2. S.C. Modesitt, and A.A. Jazaeri Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics Expert Opin Pharmacother 8 Oct 2007 2293 2305
3. G. Nucifora, L. Laricchia-Robbio, and V. Senyuk EVI1 and hematopoietic disorders: History and perspectives Gene 368 03/01 2006 1 11
4. R. Wieser The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions Gene 396 Jul 15 2007 346 357
5. K. Morishita, E. Parganas, E.C. Douglass, and J.N. Ihle Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts Oncogene 5 07 1990 963 971
6. D. Bordereaux, S. Fichelson, P. Tambourin, and S. Gisselbrecht Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs Oncogene 5 06 1990 925 927
7. C. Bartholomew, and A.M. Clark Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells Oncogene 9 03 1994 939 942
8. A. Kilbey, and C. Bartholomew Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts Oncogene 16 04/30 1998 2287 2291
9. E. Nitta, K. Izutsu, Y. Yamaguchi, Y. Imai, S. Ogawa, and S. Chiba Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP Oncogene 24 09/08 2005 6165 6173
10. J.S. Sunde, H. Donninger, K. Wu, M.E. Johnson, R.G. Pestell, and G.S. Rose Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer Cancer Res 66 Sep 1 2006 8404 8412
11. M. Nanjundan, Y. Nakayama, K.W. Cheng, J. Lahad, J. Liu, and K. Lu Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer Cancer Res 67 Apr 1 2007 3074 3084
12. Y. Liu, L. Chen, T.C. Ko, A.P. Fields, and E.A. Thompson Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT Oncogene 02/06 2006
13. L. Osterberg, K. Levan, K. Partheen, U. Delle, B. Olsson, and K. Sundfeldt Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas BMC Cancer 9 Oct 18 2009 368
14. J.J. Lin, and A. Dutta ATR pathway is the primary pathway for activating G2/M checkpoint induction after re-replication J Biol Chem 282 Oct 19 2007 30357 30362
15. A.A. Jazaeri, G.V. Chandramouli, O. Aprelikova, U.A. Nuber, C. Sotiriou, and E.T. Liu BRCA1-mediated repression of select X chromosome genes 2 J Transl Med 2 09/21 2004 32
16. U. Vinatzer, C. Mannhalter, M. Mitterbauer, H. Gruener, H. Greinix, and H.H. Schmidt Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia Genes Chromosomes Cancer 36 01 2003 80 89
17. Y.J. Machida, Y. Chen, Y. Machida, A. Malhotra, S. Sarkar, and A. Dutta Targeted comparative RNA interference analysis reveals differential requirement of genes essential for cell proliferation Mol Biol Cell 17 Nov 2006 4837 4845
18. C.P. Crum, R. Drapkin, A. Miron, T.A. Ince, M. Muto, and D.W. Kindelberger The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 Feb 2007 3 9 (Pubitemid 46095865)
19. M. Nanjundan, K.W. Cheng, F. Zhang, J. Lahad, W.L. Kuo, and R. Schmandt Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis Mol Oncol 2 Aug 2008 164 181